Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:ALDR
Delisted

Alder BioPharmaceuticals Stock Price (Quote)

$18.88
+0 (+0%)
At Close: Apr 15, 2020

Range Low Price High Price Comment
30 days $18.88 $18.88 Wednesday, 15th Apr 2020 ALDR stock ended at $18.88. During the day the stock fluctuated 0% from a day low at $18.88 to a day high of $18.88.
90 days $18.88 $18.88
52 weeks $8.39 $19.12

Historical Alder BioPharmaceuticals prices

Date Open High Low Close Volume
Feb 05, 2019 $14.13 $14.49 $13.82 $13.98 1 180 159
Feb 04, 2019 $14.17 $14.27 $13.86 $14.14 483 723
Feb 01, 2019 $14.15 $14.47 $13.86 $14.17 831 258
Jan 31, 2019 $14.10 $15.17 $13.99 $14.08 3 442 662
Jan 30, 2019 $12.10 $14.21 $12.08 $14.12 2 913 137
Jan 29, 2019 $12.53 $12.78 $11.89 $12.02 1 293 228
Jan 28, 2019 $12.85 $12.99 $12.24 $12.49 780 281
Jan 25, 2019 $12.67 $13.06 $12.49 $13.03 468 490
Jan 24, 2019 $12.24 $12.87 $12.12 $12.61 1 206 935
Jan 23, 2019 $12.72 $12.91 $12.00 $12.24 1 240 000
Jan 22, 2019 $13.27 $13.36 $12.59 $12.66 1 041 260
Jan 18, 2019 $12.38 $13.51 $12.26 $13.41 1 777 283
Jan 17, 2019 $11.72 $12.53 $11.54 $12.36 1 661 169
Jan 16, 2019 $11.57 $12.27 $11.53 $11.65 1 113 234
Jan 15, 2019 $11.11 $11.52 $11.00 $11.48 904 580
Jan 14, 2019 $10.76 $11.35 $10.66 $11.01 1 033 424
Jan 11, 2019 $10.82 $10.99 $10.58 $10.83 517 417
Jan 10, 2019 $10.22 $10.87 $10.08 $10.77 972 788
Jan 09, 2019 $10.24 $10.66 $10.21 $10.30 886 189
Jan 08, 2019 $11.25 $11.35 $10.10 $10.25 1 982 819
Jan 07, 2019 $12.02 $12.15 $10.93 $11.17 1 586 559
Jan 04, 2019 $11.24 $11.85 $10.94 $11.77 1 349 820
Jan 03, 2019 $10.89 $11.41 $10.66 $11.08 1 400 727
Jan 02, 2019 $10.11 $10.94 $9.82 $10.92 1 054 973
Dec 31, 2018 $10.22 $10.42 $10.08 $10.25 733 386
Click to get the best stock tips daily for free!

About Alder BioPharmaceuticals

Alder BioPharmaceuticals Alder BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes therapeutic antibodies in the United States and Australia. The company’s lead product candidate ALD403, an antibody, which is in Phase II clinical trial to target calcitonin gene-related peptide for the prevention of migraine. It also develops ALD1613, which is in preclinical stage to treat patients with congenital adrenal hyperpla... ALDR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT